Suchergebnisse - "Kirchgesner, Julien"

PubPharm (116)

41

Genital warts and inflammatory bowel diseases : Danish real-world evidence to assess patient-relevant outcomes

enthalten in: United European gastroenterology journal | 2022

von McLellan, P. | Kirchgesner, J.

CommentOn: United European Gastroenterol J. 2022 Apr;10(3):287-295. - PMID 35297191

42

Risk of first ischaemic stroke and use of antidopaminergic antiemetics : nationwide case-time-control study

enthalten in: BMJ (Clinical research ed.) | 2022

von Bénard-Laribière, A. | Hucteau, E. | Debette, S. | +3

CommentIn: BMJ. 2022 Apr 8;377:o924. - PMID 35396322

43

Prevalence of Self-Reported Venous Thromboembolism and Cardiovascular Risk Factors in Patients with Ulcerative Colitis: The GETAID FOCUS Study

enthalten in: Digestive diseases and sciences | 2022

von Guillo, L. | Amiot, A. | Serrero, M. | +19

44

Prevalence of Self-Reported Venous Thromboembolism and Cardiovascular Risk Factors in Patients with Ulcerative Colitis: The GETAID FOCUS Study

enthalten in: Digestive diseases and sciences | 2022

von Guillo, L. | Amiot, A. | Serrero, M. | +19

45

Prevalence of Self-Reported Venous Thromboembolism and Cardiovascular Risk Factors in Patients with Ulcerative Colitis: The GETAID FOCUS Study

enthalten in: Digestive diseases and sciences | 2022

von Guillo, L. | Amiot, A. | Serrero, M. | +19

46

Use of Proton Pump Inhibitors and Risk of Pancreatic Cancer : A Nationwide Case-Control Study Based on the French National Health Data System (SNDS)

enthalten in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology | 2022

von Lassalle, M. | Le Tri, T. | Afchain, P. | +4

47

Emulation of a randomized controlled trial in ulcerative colitis with US and French claims data : Infliximab with thiopurines compared to infliximab monotherapy

enthalten in: Pharmacoepidemiology and drug safety | 2022

von Kirchgesner, J. | Desai, R. | Schneeweiss, M. | +3

48

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2022

von Kirchgesner, J. | Beaugerie, L.

CommentOn: Clin Gastroenterol Hepatol. 2021 Aug;19(8):1602-1610.e1. - PMID 31927106

49

Risk of Serious Infections With Vedolizumab Versus Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Disease

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2022

von Kirchgesner, J. | Desai, R. | Beaugerie, L. | +2

CommentIn: Clin Gastroenterol Hepatol. 2022 Feb;20(2):e28-e30. - PMID 34022455

50

Vedolizumab Clinical Decision Support Tool Predicts Efficacy of Vedolizumab But Not Ustekinumab in Refractory Crohn's Disease

enthalten in: Inflammatory bowel diseases | 2022

von Alric, H. | Amiot, A. | Kirchgesner, J. | +6